百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONC 百济神州

交易中 04-29 15:50:26 EDT

290.91

-7.25

-2.43%

最高296.43	最低289.54	成交量13.48万
今开295.62	昨收298.16	日振幅2.31%
总市值344.93亿	流通市值220.22亿	总股本1.19亿
成交额3,929万	换手率0.18%	流通股本7,570万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":290.91,"timestamp":1777492222746,"preClose":298.16,"halted":0,"volume":134792,"delay":0,"changeRate":-0.024315803595385026,"floatShares":75698900,"shares":118570700,"eps":2.469999,"marketStatus":"交易中","change":-7.25,"latestTime":"04-29 15:50:26 EDT","open":295.62,"high":296.43,"low":289.535,"amount":39288922.794800006,"amplitude":0.023125,"askPrice":290.92,"askSize":40,"bidPrice":290.69,"bidSize":3,"shortable":3,"etf":0,"ttmEps":2.469999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777492800000},"marketStatusCode":2,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":298.16,"preHourTrading":{"tag":"盘前","latestPrice":297,"preClose":298.16,"latestTime":"09:28 EDT","volume":2114,"amount":629902.1322999999,"timestamp":1777469280061,"change":-1.16,"changeRate":-0.003891,"amplitude":0.007714},"postHourTrading":{"tag":"盘后","latestPrice":298.16,"preClose":298.16,"latestTime":"18:02 EDT","volume":435,"amount":129699.09,"timestamp":1777413726012,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.694896,"impliedVol":0.4454,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"1109645758","title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1109645758","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109645758?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:07","pubTimestamp":1777424834,"startTime":"0","endTime":"0","summary":"百济神州将于2026年05月06日发布新一季度财报，市场关注度聚焦收入增速与利润改善的持续性，以及核心产品放量节奏与费用率控制的平衡。综合一致性预期，本季度百济神州营收预计为13.36亿美元，同比增长19.61%；调整后每股收益预计为0.87美元，同比增长221.34%；息税前利润预计为1.08亿美元，同比增长243.42%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630323200","title":"盈利不足两月，百济神州豪掷20亿美元押注三抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2630323200","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630323200?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:23","pubTimestamp":1777346580,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛从“年年巨亏”到“首年盈利”，百济神州用了十五年。当这面象征盈利喜悦的旗帜刚刚升起，百济神州在此节点选择花费重金与一家biotech企业达成BD（授权交易）合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721914325.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721914325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1588","LU1719994722.HKD","BK4526","LU1303224171.USD","688235","BK4585","BK0239","LU2328871848.SGD","BK1161","LU1251922891.USD","06160","ONC","BK4139","BK1583","BK4588","LU0307460666.USD","BK1500","LU0588546209.SGD","LU1770034418.SGD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393872","title":"百济神州(06160)与华辉安健签订《合作协议》引进三特异性创新药全球独家开发权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393872","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630393872?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:03","pubTimestamp":1777287828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2026 年 4 月 24 日，公司全资子公司百济神州广州与华辉安健签订了一份《合作协议》。此外，华辉安健同意在相关里程碑达成后，向百济神州广州支付其被百济神州广州授予相关知识产权许可的对价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1719994722.HKD","159992","BK1500","BK4585","BK4139","LU1251922891.USD","LU0307460666.USD","BK0239","06978","LU1770034418.SGD","BK1574","06160","LU1303224171.USD","BK1588","LU2328871848.SGD","688235","BK4588","BK1161","BK1583","ONC","LU0588546209.SGD","BK4526","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628093746","title":"百济神州：公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定","url":"https://stock-news.laohu8.com/highlight/detail?id=2628093746","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628093746?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:30","pubTimestamp":1776677400,"startTime":"0","endTime":"0","summary":"证券日报网讯4月20日，百济神州在互动平台回答投资者提问时表示，公司已在2026年4月15日披露的《百济神州2025年年度报告》中详细披露报告期内的公司营业收入、销售费用、管理费用的变动原因。公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定，财务数据客观公允反映公司财务状况和生产经营成果，不存在跨期结转成本费用的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710742828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4139","688235","LU1303224171.USD","BK4585","LU2328871848.SGD","BK1583","BK4526","LU1770034418.SGD","LU0307460666.USD","LU1719994722.HKD","LU1969619763.USD","BK4588","06160","BK1588","LU1251922891.USD","LU0588546209.SGD","BK1500","ONC","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627328932","title":"2025年A股药企薪酬：药明康德李革年薪3998万，百济神州人均薪酬94万","url":"https://stock-news.laohu8.com/highlight/detail?id=2627328932","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627328932?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:00","pubTimestamp":1776250843,"startTime":"0","endTime":"0","summary":"红星资本局4月15日消息，随着年报季到来，A股已有超120家医药企业披露了2025年经营业绩，其员工薪酬也受到关注。红星资本局根据企业年报、数据统计发现，药明康德（603259.SH；2359.HK）创始人李革以3998万元的年薪暂列药企管理层第一，较第二名高出1800多万元，其连续位列A股管理层薪酬榜首。人均薪酬方面，百济神州达到94.63万元，位居第一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153706121691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1688375341.USD","LU0708995583.HKD","LU1242518857.USD","BK1583","LU0039217434.USD","LU0051755006.USD","LU0572944931.SGD","LU2125910500.SGD","LU0417516902.SGD","06160","LU0456842615.SGD","LU0588546209.SGD","BK1589","LU1720050803.USD","LU1719994722.HKD","399300","LU1969619763.USD","LU2488822045.USD","ONC","BK4139","SG9999002562.SGD","BK4526","LU1770034418.SGD","159982","LU0043850808.USD","LU0856984785.SGD","IE00B0JY6N72.USD","688235","LU1808992512.USD","LU1997244956.HKD","LU0320764599.SGD","LU0516422366.SGD","LU2328871848.SGD","LU1979443071.USD","LU1997245094.SGD","02269","BK1576","LU2495084118.USD","603259","LU1046422090.SGD","LU2039709279.SGD","LU0327786744.USD","LU0348825331.USD","LU1934453819.USD","02359","LU3063872942.SGD","LU2242644610.SGD","BK1610","BK4588","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627415479","title":"百济神州年营收382亿：净利14.6亿 安进与Baker是核心股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2627415479","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627415479?lang=zh_cn&edition=full","pubTime":"2026-04-15 09:52","pubTimestamp":1776217938,"startTime":"0","endTime":"0","summary":"百济神州有限公司（公司代码：688235 公司简称：百济神州）日前发布截至2025年12月31日的财报。财报显示，百济神州2025年营收为382.25亿，较上年同期的272亿增长40.46%；","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33283/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["688235","ONC","06160","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445534","title":"百济神州(688235.SH)发布2025年度业绩，扭亏为盈至14.61亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445534","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627445534?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:39","pubTimestamp":1776173982,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布2025年年度报告，报告期内，公司实现营业收入382.25亿元，同比增长40.46%。实现归属于上市公司股东的净利润14.61亿元。2023年1月，根据两项3期试验结果，百悦泽获批用于治疗初治和复发性CLL或SLL成年患者。2024年3 月，百悦泽联合奥妥珠单抗获得FDA加速批准用于治疗R/RFL患者。2025年6月，FDA批准百悦泽的薄膜包衣片剂剂型用于所有已获批适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK4139","BK0239","ONC","BK4588","BK1161","BK1583","BK4585","BK1588","LU0588546209.SGD","LU1719994722.HKD","BK1500","BK4526","LU1251922891.USD","LU1770034418.SGD","LU1303224171.USD","688235","LU1969619763.USD","LU0307460666.USD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626195663","title":"百济神州安泰适在中国获得上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2626195663","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626195663?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:26","pubTimestamp":1775813160,"startTime":"0","endTime":"0","summary":"百济神州公司宣布，安泰适?（注射用塔拉妥单抗）经优先审评程序获得国家药品监督管理局（NMPA）附条件批准，用于既往接受过至少2种系统性（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。塔拉妥单抗是首个且目前唯一获批的靶向DLL3和CD3的双特异性T细胞衔接器（TCE）抗体，由百济神州与安进公司（Amgen）共同负责其在中国大陆开发和商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604103701225141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","BK4139","BK0239","ONC","LU2328871848.SGD","LU0307460666.USD","BK4585","06160","LU1770034418.SGD","BK4588","BK1161","BK4526","LU1251922891.USD","LU1303224171.USD","BK1500","LU0588546209.SGD","688235","LU1719994722.HKD","BK1583","IPOS","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625128969","title":"百济神州(06160)授出合共1.77万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2625128969","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625128969?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:27","pubTimestamp":1775640476,"startTime":"0","endTime":"0","summary":"百济神州(06160)发布公告，于2026年3月31日，董事会薪酬委员会根据2016期权及激励计划的条款授予154名承授人合共1.77万股美国存托股份受限制股份单位。该等受限制股份单位相当于22.98万股股份，约占本公告之日公司发行股份总数的0.01%。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06160","BK1161","BK4588","LU0588546209.SGD","BK0239","BK1588","LU1719994722.HKD","ONC","LU1303224171.USD","LU2328871848.SGD","BK4526","LU1969619763.USD","LU0307460666.USD","BK1583","BK4139","688235","LU1251922891.USD","BK4585","BK1500","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622206073","title":"百济神州：2025年净利润2.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622206073","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622206073?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:10","pubTimestamp":1774440632,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月25日，百济神州公告，2025年收入53.43亿美元，同比增长40.2%；净利润2.87亿美元，上年同期净亏损6.45亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684282696.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684282696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618972362","title":"百济神州(06160)根据股份计划发行74.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618972362","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618972362?lang=zh_cn&edition=full","pubTime":"2026-03-12 07:44","pubTimestamp":1773272679,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月11日根据股份计划发行74.13万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK4588","BK4139","LU1969619763.USD","688235","LU0588546209.SGD","BK4526","ONC","BK1588","LU0307460666.USD","BK0239","BK4585","LU1251922891.USD","LU1303224171.USD","BK1500","LU1770034418.SGD","06160","BK1583","LU1719994722.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618917443","title":"科创板成长层首批“退层”企业出炉！百济神州、寒武纪等在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917443","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917443?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:40","pubTimestamp":1773218438,"startTime":"0","endTime":"0","summary":"据统计，截至3月11日，科创板全体公司均以业绩快报或预告形式完成对2025年经营情况的披露，预计将实现营业收入1.59万亿元，同比增长10.3%；净利润591亿元，同比增长28.2%。随着业绩的集中披露，科创板成长层也将迎来首批“退层”公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1345,202603113668838022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LU2476274720.SGD","LU2778985437.USD","BK1161","BK0231","BK4139","SG9999002950.SGD","688256","SGXZ81163826.USD","688235","LU1303224171.USD","SG9999001069.SGD","BK4585","LU2476274308.USD","LU2328871848.SGD","BK1583","SG9999001093.SGD","SGXZ49509284.SGD","BK4526","SGXZ90724238.SGD","LU1770034418.SGD","LU0307460666.USD","SG9999006597.SGD","LU1719994722.HKD","BK4588","06160","LU1969619763.USD","BK1588","LU1251922891.USD","SG9999003461.SGD","LU0588546209.SGD","159982","SG9999001051.SGD","BK1500","ONC","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618293810","title":"百济神州(06160)：2018 员工购股计划的新一轮认购期自3月2日起至8月31日止","url":"https://stock-news.laohu8.com/highlight/detail?id=2618293810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618293810?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:53","pubTimestamp":1773132798,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2018 员工购股计划的新一轮认购期自2026年3月2日起至2026年8月31日止。2018员工购股计划使合资格雇员可按市价15%折让申购股份。雇员可于认购期结束后购买股份，购股资金可从其认购期内所得薪金中扣除。本公司相信，持续为本公司雇员提供通过参与2018员工购股计划获得本公司所有权权益的机会，鼓励其继续受雇于本公司，并使其利益与本公司股东的利益更紧密地保持一致，符合本公司及股东的最佳利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0307460666.USD","LU2328871848.SGD","BK4526","BK4588","LU1770034418.SGD","LU1303224171.USD","BK0239","LU0588546209.SGD","LU1251922891.USD","BK4585","BK4139","BK1583","688235","06160","BK1161","LU1969619763.USD","BK1588","ONC","BK1500","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618009613","title":"营收382亿！创新药“一哥”百济神州，全面扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2618009613","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618009613?lang=zh_cn&edition=full","pubTime":"2026-03-09 10:37","pubTimestamp":1773023833,"startTime":"0","endTime":"0","summary":"2月26日晚，百济神州发布2025年业绩快报。然而，面对业绩全面扭亏，市场反应冷淡。财报发布后，百济神州美股两个交易日跌幅超10%。业绩快报显示，百济神州产品收入377.70亿元，同比增长39.9%，主要由百悦泽、安进授权产品及百泽安销售增长驱动。具体来看，2025年百悦泽全球销售额280.67亿元，同比增长48.8%，创历史新高；百泽安全球销售额52.97亿元，同比增长18.6%。随着适应症持续拓展，百济神州已具备头部药企竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1772409403580961090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159992","ONC","688235","06978","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617666539","title":"百济神州授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617666539","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617666539?lang=zh_cn&edition=full","pubTime":"2026-03-08 10:31","pubTimestamp":1772937060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-08/doc-inhqfsut4635660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0588546209.SGD","BK4139","688235","BK1583","LU0307460666.USD","LU2328871848.SGD","06160","BK4585","LU1719994722.HKD","LU1770034418.SGD","ONC","LU1303224171.USD","LU1251922891.USD","BK0239","BK1588","BK1500","LU1969619763.USD","BK4588","BK1161","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617068639","title":"百济神州(06160)授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617068639","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617068639?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:20","pubTimestamp":1772788807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1770034418.SGD","LU1969619763.USD","LU2328871848.SGD","BK1588","BK4588","LU0307460666.USD","ONC","BK1500","LU1719994722.HKD","LU1251922891.USD","BK4585","BK0239","LU1303224171.USD","688235","BK4526","BK4139","LU0588546209.SGD","06160","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617661566","title":"百济神州“增长之问”：泽布替尼美国市占率登顶后，下一个五年能走多远？","url":"https://stock-news.laohu8.com/highlight/detail?id=2617661566","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617661566?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:33","pubTimestamp":1772616836,"startTime":"0","endTime":"0","summary":"百济神州方面指出。这种“增量不减”的态势，离不开泽布替尼全球化布局的深化。其中2025年Q4，泽布替尼的中国地区增速有所下滑，销售额8600万美元，环比下降6.87%，欧洲地区销售额1.67亿美元，环比增长2.45%。2025年Q3，泽布替尼的美国市场占有率达到33.8%，超过伊布替尼成为第一名，全球市场占有率在2025年Q4突破30%。百济神州方面表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041812149542f65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041812149542f65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ONC","BK4526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616580089","title":"超130家药企亏损太惊人，318家晒2025成绩单！百济神州、特宝生物净利润首破10亿，奇正、千金……亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580089","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616580089?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:32","pubTimestamp":1772613166,"startTime":"0","endTime":"0","summary":"截至目前，医药企业已有318家披露成绩单，其中近130家是业绩快报，华润三九、奇正藏药、千金药业等业绩双涨。此外，有超过130家亏损，智飞生物首亏超过100亿元。17家净利润超10亿，华润三九、奇正、千金……其中，药明康德以191.51亿元领跑，三生国健、艾力斯首次晋身20亿元梯队，百济神州、特宝生物首次突破10亿元大关。从亏损金额来看，1亿元及以上占比超6成，智飞生物亏损最多，超过100亿元，也是公司上市以来首亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163930a44a75e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163930a44a75e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146097023","title":"异动解读 | 百济神州盘中大跌5.34%，港股创新药板块回调资金“利好出尽”撤离","url":"https://stock-news.laohu8.com/highlight/detail?id=1146097023","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146097023?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:53","pubTimestamp":1772549595,"startTime":"0","endTime":"0","summary":"百济神州（ONC）今日盘中股价大跌5.34%，引起了市场的广泛关注。消息面上，此次下跌与港股创新药板块整体大幅回调有关，百济神州在板块中领跌。尽管公司此前发布了强劲的2025年业绩，实现营业总收入同比增长40.4%并成功扭亏为盈，但部分资金选择“利好出尽”式撤离，这是A股和港股市场常见的博弈行为。同时，市场对创新药企的定价逻辑正在发生根本性转变，从单纯看重管线储备转向研发能力、商业化能力与合规能力的综合考量。资金面上，外资持续流出港股医药板块，南向资金转向科技、高股息板块，港股创新药ETF近期出现净赎回，资金获利了结情绪集中释放，共同导致了股价的短期承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616297723","title":"首次全年盈利，百济神州为何股价三地齐跌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2616297723","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616297723?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:49","pubTimestamp":1772549340,"startTime":"0","endTime":"0","summary":"中新网北京3月3日电(记者赵方园)一度被冠以“烧钱一哥”的A股创新药龙头百济神州，终于在2025年迎来了历史性转折。近期，百济神州发布2025年度业绩快报，报告期内实现营业总收入382.05亿元，同比增长40.4%；归属于上市公司股东的净利润14.22亿元。而在2024年同期，公司亏损49.78亿元。这是百济神州成立十六年以来首次实现全年盈利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603033660707240.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603033660707240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1719994722.HKD","688235","BK1500","BK4139","BK4588","LU2328871848.SGD","BK4526","BK1161","ONC","BK1583","BK0239","06160","BK1588","LU1251922891.USD","BK4585","LU1770034418.SGD","LU0588546209.SGD","LU1303224171.USD","LU0307460666.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0453},{"period":"1month","weight":0.0535},{"period":"3month","weight":-0.1481},{"period":"6month","weight":-0.0326},{"period":"1year","weight":0.1952},{"period":"ytd","weight":-0.0186}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"　　百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.454545,"avgChangeRate":0.019717},{"month":5,"riseRate":0.4,"avgChangeRate":-0.019094},{"month":6,"riseRate":0.5,"avgChangeRate":0.012468},{"month":7,"riseRate":0.8,"avgChangeRate":0.147208},{"month":8,"riseRate":0.6,"avgChangeRate":0.034201},{"month":9,"riseRate":0.6,"avgChangeRate":0.069537},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004517},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,ONC,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}